Product Program year 2021 Source: CMS Open Payments

AngioVac

Device Endovascular Therapies

PDI H965252000

Open in the dashboard

General payments

$186,402

38 payments

Research payments

$57,700

17 payments

Through program year 2021, $186,402 in general payments and $57,700 in research payments were reported against AngioVac (Endovascular Therapies).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $186,402 38
2021 Research $57,700 17

Breakdown

Who paid General payments · program year 2021
  1. AngioDynamics, Inc. $186,402 38 payments
Top recipients General payments · program year 2021
  1. John Moriarty Vascular & Interventional Radiology · Los Angeles, CA $49,259 26% · 2 payments
  2. Matthew Wiisanen Interventional Cardiology · Chattanooga, TN $17,298 9% · 3 payments
  3. Mark Joseph Thoracic Surgery (Cardiothoracic Vascular Surgery) · Roanoke, VA $16,750 9% · 2 payments
  4. Andy Kiser Surgery · Pittsburgh, PA $16,725 9% · 1 payment
  5. David Zlotnick Interventional Cardiology · Buffalo, NY $14,950 8% · 2 payments

The top 5 of 30 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Vascular & Interventional Radiology Radiology $67,784 36% · 4 practitioners
  2. Thoracic Surgery (Cardiothoracic Vascular Surgery) $54,266 29% · 7 practitioners
  3. Interventional Cardiology Internal Medicine $37,673 20% · 9 practitioners
  4. Surgery $16,725 9% · 1 practitioner
  5. Cardiovascular Disease Internal Medicine $9,253 5% · 7 practitioners

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. California $59,711 32% · 3 recipients
  2. Tennessee $28,452 15% · 2 recipients
  3. New York $19,650 11% · 4 recipients
  4. Pennsylvania $17,075 9% · 2 recipients
  5. Virginia $16,750 9% · 1 recipient

The top 5 of 15 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

38 general · 17 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record